283 related articles for article (PubMed ID: 24666998)
1. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma.
Johnson ME; Zhu F; Li T; Wu H; Galloway TJ; Farma JM; Perlis CS; Turaka A
J Am Acad Dermatol; 2014 Jun; 70(6):1028-35. PubMed ID: 24666998
[TBL] [Abstract][Full Text] [Related]
2. A high neutrophil-to-lymphocyte ratio as a potential marker of mortality in patients with Merkel cell carcinoma: A retrospective study.
Zaragoza J; Kervarrec T; Touzé A; Avenel-Audran M; Beneton N; Esteve E; Wierzbicka Hainaut E; Aubin F; Machet L; Samimi M
J Am Acad Dermatol; 2016 Oct; 75(4):712-721.e1. PubMed ID: 27544490
[TBL] [Abstract][Full Text] [Related]
3. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
Smith VA; Camp ER; Lentsch EJ
Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
[TBL] [Abstract][Full Text] [Related]
4. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
Smith VA; MaDan OP; Lentsch EJ
Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
[TBL] [Abstract][Full Text] [Related]
5. Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation.
Arron ST; Canavan T; Yu SS
J Am Acad Dermatol; 2014 Oct; 71(4):684-90. PubMed ID: 24993599
[TBL] [Abstract][Full Text] [Related]
6. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease.
Foote M; Veness M; Zarate D; Poulsen M
J Am Acad Dermatol; 2012 Sep; 67(3):395-9. PubMed ID: 22030017
[TBL] [Abstract][Full Text] [Related]
7. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Role of Tumoral PD-L1 and IDO1 Expression, and Intratumoral CD8+ and FoxP3+ Lymphocyte Infiltrates in 132 Primary Cutaneous Merkel Cell Carcinomas.
Donizy P; Wu CL; Kopczynski J; Pieniazek M; Biecek P; Ryś J; Hoang MP
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071045
[TBL] [Abstract][Full Text] [Related]
9. Merkel cell carcinomas infiltrated with CD33
Kervarrec T; Gaboriaud P; Berthon P; Zaragoza J; Schrama D; Houben R; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Domenech J; Guyétant S; Touzé A; Samimi M
J Am Acad Dermatol; 2018 May; 78(5):973-982.e8. PubMed ID: 29273486
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?
Sandel HD; Day T; Richardson MS; Scarlett M; Gutman KA
Laryngoscope; 2006 May; 116(5):791-5. PubMed ID: 16652089
[TBL] [Abstract][Full Text] [Related]
11. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab.
Oki Y; Yamamoto K; Kato H; Kuwatsuka Y; Taji H; Kagami Y; Morishima Y
Eur J Haematol; 2008 Dec; 81(6):448-53. PubMed ID: 18691256
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma.
Jouary T; Kubica E; Dalle S; Pages C; Duval-Modeste AB; Guillot B; Mansard S; Saiag P; Aubin F; Bedane C; Dalac S; Dompmartin A; Granel-Brocard F; Lok C; Stoebner PE; Lacour JP; Leccia MT; Diallo A; Ezzedine K; Mateus C
Acta Derm Venereol; 2015 Sep; 95(7):835-40. PubMed ID: 25784178
[TBL] [Abstract][Full Text] [Related]
13. Merkel cell carcinoma of the skin: a retrospective study of 24 cases by the Hellenic Cooperative Oncology Group.
Pectasides D; Papaxoinis G; Pectasides E; Galani H; Razi E; Katodrytis N; Fountzilas G; Economopoulos T
Oncology; 2007; 72(3-4):211-8. PubMed ID: 18176086
[TBL] [Abstract][Full Text] [Related]
14. A better prognosis for Merkel cell carcinoma of unknown primary origin.
Chen KT; Papavasiliou P; Edwards K; Zhu F; Perlis C; Wu H; Turaka A; Berger A; Farma JM
Am J Surg; 2013 Nov; 206(5):752-7. PubMed ID: 23835211
[TBL] [Abstract][Full Text] [Related]
15. Clinical course and prognostic factors of Merkel cell carcinoma of the skin.
Güler-Nizam E; Leiter U; Metzler G; Breuninger H; Garbe C; Eigentler TK
Br J Dermatol; 2009 Jul; 161(1):90-4. PubMed ID: 19438439
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.
Paulson KG; Iyer JG; Tegeder AR; Thibodeau R; Schelter J; Koba S; Schrama D; Simonson WT; Lemos BD; Byrd DR; Koelle DM; Galloway DA; Leonard JH; Madeleine MM; Argenyi ZB; Disis ML; Becker JC; Cleary MA; Nghiem P
J Clin Oncol; 2011 Apr; 29(12):1539-46. PubMed ID: 21422430
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant local irradiation for Merkel cell carcinoma.
Lewis KG; Weinstock MA; Weaver AL; Otley CC
Arch Dermatol; 2006 Jun; 142(6):693-700. PubMed ID: 16785371
[TBL] [Abstract][Full Text] [Related]
18. Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.
Sun D; Elson P; Liedtke M; Medeiros BC; Earl M; Alizadeh A; Bates J; Sekeres MA; Coutre S; Kalaycio M; Sobecks R; Copelan E; Advani AS
Am J Hematol; 2012 Oct; 87(10):957-60. PubMed ID: 22729847
[TBL] [Abstract][Full Text] [Related]
19. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
20. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.
Porrata LF; Ristow K; Habermann TM; Witzig TE; Inwards DJ; Markovic SN
Am J Hematol; 2009 Feb; 84(2):93-7. PubMed ID: 19123458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
